Skip to main content

Advertisement

Log in

Management of acute hypercortisolism

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

An occasional patient with Cushing's syndrome may require urgent management primarily because the chronic ravages of hypercortisolism have caused the patient to be in a precarious metabolic condition. The side effects of prolonged excess corticosteroids increase the risk of operations in such patients and must be considered in overall management. Among the many effects of hypercortisolism to be considered are hypertension, diabetes, ocular hypertension, myopathies, dermatologic changes including skin infection, pancreatitis, osteoporosis, pathological fractures, peptic ulcers, renal calculi, coagulopathies, hypokalemia, poor wound healing, and increased susceptibility to infection. The most effective way to avert these complications is by earlier diagnosis and definitive treatment of Cushing's syndrome. The present report includes a review of the etiology and diagnosis of Cushing's syndrome and the management of problems associated with hypercortisolism.

Résumé

Il est possible qu'un malade atteint de maladie de Cushing ait besoin d'être traité sans attente en raisons de troubles métaboliques sévères dus aux effets nocifs de l'hypercortisolisme chronique qui augmentent les risques opératoires et doivent être pris en considération avant tout traitement. Il en est ainsi de l'hypertension, du diabète, de l'hypertension intra-oculaire, des lésions dermiques comprenant l'infection cutanée, la pancréatite, l'ostéoporose, les fractures pathologiques, l'ulcère peptique, les calculs rénaux, les coagulopathies, l'hypokaliémie, la lenteur du processus de cicatrisation et l'augmentation de la suceptibilité à l'infection.

Le meilleur moyen d'éviter ces complications est de porter sans retard le diagnostic de maladic de Cushing et de la traiter radicalement dès que le diagnostic est posé.

Le présent rapport comporte une revue de l'étiologie et du diagnostic de la maladie de Cushing ainsi que du traitement des problèmes qui sont associés à l'hypercortisolisme.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hardy, J.D., Chavez, C.M.: Endocrine emergencies. In Critical Surgical Illness, J.D. Hardy, editor, Philadelphia, W.B. Saunders, 1971, pp. 523–526

    Google Scholar 

  2. Hardy, J.D., Langford, H.G.: Surgical management of Cushing's syndrome: Including studies of adrenal autotransplants, body composition and pseudotumor cerebri. Ann. Surg.159:711, 1964

    Google Scholar 

  3. Travis, R.H.: Cushing's syndrome. In Current Therapy 1980, H.F. Conn, editor, Philadelphia, W.B. Saunders, 1980, pp. 481–485

    Google Scholar 

  4. Becker, K.L.: Corticosteroids: Many of their side effects are really their action. Drug Therapy, December, 1981, pp. 75–80

  5. Cushing, H.: The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull. Johns Hopkins Hosp.50:137, 1932

    Google Scholar 

  6. Grapo, L.: Cushing's syndrome: Diagnostic tests, Metabolism28:955, 1979

    Google Scholar 

  7. Hardy, J.: Transsphenoidal microsurgical removal of pituitary microadenomas. Prog. Neurol. Surg.6:200, 1975

    Google Scholar 

  8. Javadpour, N., Woltering, E.A., Brennan, M.F.: Adrenal neoplasms. Curr. Probl. Surg.17:1, 1980

    Google Scholar 

  9. Montgomery, D., Welbourn, R.B.: Cushing's syndrome: Twenty years after adrenalectomy. Br. J. Surg.65:221, 1978

    Google Scholar 

  10. Salassa, R.M., Laws, E.R., Carpenter, P.C.: Transsphenoidal removal of pituitary adenoma in Cushing's disease. Mayo Clin. Proc.53:24, 1978

    Google Scholar 

  11. Schteingart, D.E., Tsao, H.S., Taylor, C.L., McKenzie, A., Victoria, R., Therrien, B.A.: Sustained remission of Cushing's disease with mitotane and pituitary irradiation. Ann. Intern. Med.92:613, 1980

    Google Scholar 

  12. Tyrrell, J.B., Brooks, R.M., Fitzgerald, P.A., Cofoid, P.B., Forsham, P.N., Wilson, C.B.: Cushing's disease: Selective transsphenoidal resection of pituitary adenomas. N. Engl. J. Med.298:753, 1960

    Google Scholar 

  13. Wilson, C.B., Tyrrell, J.B., Fitzgerald, P.: Cushing's disease revisited. Am. J. Surg.138:77, 1979

    Google Scholar 

  14. Nathanson, L., Hall, T.C.: Lung tumors: How they produce their syndromes. Ann. N.Y. Acad. Sci.230:367, 1974

    Google Scholar 

  15. Samaan, N.A.: Hormone production in nonendocrine tumors. Cancer273:148, 1977

    Google Scholar 

  16. Schteingart, D.D., Motazedi, A., Noonan, R.A., et al.: The treatment of adrenal carcinomas. Arch. Surg.(in press)

  17. Thompson, N.W.: Adrenal lesions causing hypertension: Surgical treatment. Urol. Radiol.(in press)

  18. Liddle, G.W.: Test of pituitary adrenal suppressibility in the diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metab.20:153, 1960

    Google Scholar 

  19. Levine, H.L., Post, K.D.: The pituitary gland, vol. 3. In Surgical Radiology, J.G. Teplick, M.E. Haskin, editors, Philadelphia, W.B. Saunders, 1981

    Google Scholar 

  20. Bigos, S.T., Somma, M., Rasio, E., Eastman, R.C., Lanthier, A., Johnston, H.H., Hardy, J.: Cushing's disease: Management by transsphenoidal pituitary microsurgery. J. Clin. Endocrinol. Metab.50:348, 1980

    Google Scholar 

  21. Prinz, R.A., Brooks, M.D., Lawrence, A.M., Paloyan, E.: Cushing's disease: The role of adrenalectomy and autotransplantation. Surg. Clin. North Am.59:159, 1979

    Google Scholar 

  22. Nelson, D.H., Mecklin, J.W., Thorn, G.W.: ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome. Ann. Intern. Med.52:560, 1960

    Google Scholar 

  23. Moore, T.J., Dluhy, R.G., Williams, G.H., Cain, J.P.: Nelson's syndrome: Frequency, prognosis, and effect of prior pituitary irradiation Ann. Intern. Med.85:731, 1976

    Google Scholar 

  24. Thrall, J.H., Freitas, J.E., Beierwaltes, W.H.: Adrenal scintigraphy. Semin. Nucl. Med.8:23, 1978

    Google Scholar 

  25. Luton, J.P., Mahoudeau, J.A., Bouchard, P., Thieblot, P., Hautecouverture, M., Simon, D., Laudat, M.N., Touitou, Y., Bricaire, H.: Treatment of Cushing's disease by o,p′-DDD, N. Engl. J. Med.300:459, 1979

    Google Scholar 

  26. George, W.F., Husain, M., Lock, J.P., Katz, F.H.: Failure of cyproheptadine to inhibit vasopressin stimulated cortisol release in a patient with Cushing's disease. Horm. Res.7:308, 1976

    Google Scholar 

  27. Krieger, D.T., Amorosa, L., Linick, F.: Cyproheptadine-induced remission of Cushing's disease. N. Engl. J. Med.293:893, 1975

    Google Scholar 

  28. O'Ercole, A.J., Morris, M.A., Underwood, L.E., VanWyk, J.J.: Treatment of Cushing's disease in childhood with cyproheptadine. J. Pediatr.90:834, 1977

    Google Scholar 

  29. Lamberts, S.W.J., Birkenhager, J.C.: Effect of bromocryptine in pituitary-dependent Cushing's syndrome. J. Endocrinol.70:315, 1976

    Google Scholar 

  30. Spark, R.E., Baker, R., Brenfank, O.C., Bergland, R.: Bromocryptine reduces pituitary tumor size and hypersecretion. J.A.M.A.247:311, 1982

    Google Scholar 

  31. Girard, J., Baumann, J.B., Bühler, U., Zuppinger, K., Haas, H.G., Staub, J.J., Wyss, H.I.: Cyproterone acetate and ACTH adrenal function. J. Clin. Endocrinol. Metab.47:581, 1978

    Google Scholar 

  32. Krieger, D.: Lack of responsiveness to L-DOPA in Cushing's disease. J. Clin. Endocrinol. Metab.36:277, 1973

    Google Scholar 

  33. Temple, T.E., Liddle, G.W.: Inhibition of adrenal steroid biosynthesis. Ann. Rev. Pharmacol. Toxicol.10:199, 1970

    Google Scholar 

  34. Orth, D.N.: Metyrapone is useful only as an adjunctive therapy in Cushing's disease. Ann. Intern. Med.89:128, 1978

    Google Scholar 

  35. Call, R., Horner, I., Kraiem, Z., Gafni, J.: Successful metyrapone therapy of the ectopic ACTH syndrome. Ann. Intern. Med.92:613, 1980

    Google Scholar 

  36. Jeffcoate, W.J., Rees, L.H., Tomlin, S., Jones, A.E., Edwards, C.R.W., Besser, G.M.: Metyrapone in long-term management of Cushing's disease. Br. Med. J.2:215, 1977

    Google Scholar 

  37. Touiton, Y., Bogdan, A., Legrand, J.C., et al.: Aminoglutethimide and glutethimide: Effects of 18-hydroxycorticosterone biosynthesis by human and sheep adrenals in vitro. Acta Endocrinol.80:575, 1975

    Google Scholar 

  38. Schteingart, D.E., Cash, R., Conn., J.W.: Aminoglutethimide and metastatic adrenal cancer. J.A.M.A.198:1007, 1966

    Google Scholar 

  39. Smilo, R., Earll, J., Forsham, P.: Suppression of tumorous adrenal hyperfunction by aminoglutethimide. Metabolism16:374, 1967

    Google Scholar 

  40. Gordon, P., Becker, C., Levey, G., Roth, J.: Efficacy of aminoglutethimide in the ectopic ACTH syndrome. J. Clin. Endocrinol. Metab.29:921, 1969

    Google Scholar 

  41. Misbin, R.I., Canary, J., Willard, D.: Aminogluthethimide in the treatment of Cushing's syndrome. J. Clin. Pharmacol.16:645, 1976

    Google Scholar 

  42. Meikle, A.W., Tyler, E.H.: Potency and duration of action of gluococorticoids. Am. J. Med.65:200, 1977

    Google Scholar 

  43. Fraser, C.G., Preuss, F.S., Bigford, W.D.: Adrenal atrophy and irreversible shock associated with cortisone therapy. J.A.M.A.149:1542, 1952

    Google Scholar 

  44. Byyny, R.L.: Withdrawal from glucocorticoid therapy. N. Engl. J. Med.295:30, 1976

    Google Scholar 

  45. Plager, J.E., Cushman, P. Jr.: Suppression of the pituitary-ACTH response in man by administration of ACTH or cortisol. J. Clin. Endocrinol. Metab.22:147, 1962

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thompson, N.W., Allo, M.D. Management of acute hypercortisolism. World J. Surg. 6, 748–756 (1982). https://doi.org/10.1007/BF01655367

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01655367

Keywords

Navigation